Gasporox AB (publ)
Gasporox AB (publ) engages in the development and commercialization of tunable diode laser absorption spectroscopy technology in Sweden. The company offers Instruments, such as GPX1500 vial, GPX1500 film pharma, and GPX1500 film food; linearch machines; VialArch, BottleArch, AutoMAP pharma and food, and CellSpect sensors; and GPX HMI software. It also provides laboratory services, including alpha… Read more
Gasporox AB (publ) (GPX) - Total Liabilities
Latest total liabilities as of September 2025: Skr27.82 Million SEK
Based on the latest financial reports, Gasporox AB (publ) (GPX) has total liabilities worth Skr27.82 Million SEK as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Gasporox AB (publ) - Total Liabilities Trend (2013–2024)
This chart illustrates how Gasporox AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Gasporox AB (publ) Competitors by Total Liabilities
The table below lists competitors of Gasporox AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Noronex Ltd
AU:NRX
|
Australia | AU$1.22 Million |
|
Carmell Therapeutics Corporation
NASDAQ:CTCX
|
USA | $7.14 Million |
|
XWELL Inc.
NASDAQ:XWEL
|
USA | $18.68 Million |
|
Wahana Pronatural
JK:WAPO
|
Indonesia | Rp98.34 Billion |
|
Ronin Resources Ltd
AU:RON
|
Australia | AU$121.73K |
|
Avalon GloboCare Corp.
NASDAQ:ALBT
|
USA | $13.62 Million |
|
Wellard Ltd
AU:WLD
|
Australia | AU$2.67 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down Gasporox AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.72 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.60 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Gasporox AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Gasporox AB (publ) (2013–2024)
The table below shows the annual total liabilities of Gasporox AB (publ) from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr13.28 Million | -34.68% |
| 2023-12-31 | Skr20.33 Million | +1.68% |
| 2022-12-31 | Skr19.99 Million | +128.70% |
| 2021-12-31 | Skr8.74 Million | +23.69% |
| 2020-12-31 | Skr7.07 Million | +3.59% |
| 2019-12-31 | Skr6.82 Million | +40.72% |
| 2018-12-31 | Skr4.85 Million | -2.14% |
| 2017-12-31 | Skr4.95 Million | +32.35% |
| 2016-12-31 | Skr3.74 Million | +176.85% |
| 2015-12-31 | Skr1.35 Million | -72.16% |
| 2014-12-31 | Skr4.86 Million | +178.66% |
| 2013-12-31 | Skr1.74 Million | -- |